Shape Therapeutics
Latest round
- Series B
Last raised
- Jul 2021
Total raised
- $148M
Investors
- 6
About Shape Therapeutics
, trading under the name ShapeTX, is a biotechnology company developing RNA technologies. Francois Vigneault is the current CEO of the company. In July 2021, Shape Therapeutics, Inc. ShapeTX is a gene therapy platform designed to facilitate the treatment of neurodegenerative disorders, oncology, metabolic, and rare genetic diseases, such as Parkinson’s disease, Alzheimer’s disease, alpha-1 antitrypsin deficiency, and Rett syndrome. The company has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing, and RNA replacement for patients suffering from genetic disorders with high unmet needs. Its solutions include Payload – RNA Fix, Payload – RNA Skip, and Delivery – AAVid. The company plans to continue building its growing portfolio of RNA technologies into broad industry verticals while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities.
Who invested in Shape Therapeutics
6 investors across 2 rounds
See all investors in Shape Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shape Therapeutics
Who invested in Shape Therapeutics?
Shape Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shape Therapeutics raised?
Shape Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Shape Therapeutics last raise money?
Shape Therapeutics's most recent round on record is a Series B, in Jul 2021.
What does Shape Therapeutics do?
, trading under the name ShapeTX, is a biotechnology company developing RNA technologies.
Where is Shape Therapeutics headquartered?
Shape Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Shape Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Shape Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Shape Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.